A virtual event presented by the Financial Times and Nikkei Inc
More than 18 months after the COVID-19 pandemic began, the world is still reeling from its economic, social and health impact. In Asia, control of the disease has been uneven, as has medical care available for the infected. Developed nations in general have weathered the crisis better than the lesser developed, but the process has been devastating for all. Along the way, the pandemic has exposed the weaknesses not only in the region’s overall health systems but also in specific related sectors such as geriatric care and insurance.
What policies should the region’s health authorities and governments pursue to improve their health systems? How can they balance the needs—often disparate—of their public and private health sectors? For their part, how can businesses and investors in hospital chains, medical equipment, pharmaceuticals and insurance play a vital role? Are cross-border synergies possible or desirable in Asia’s healthcare map? How has the pandemic changed the forecast over the next few years for the region’s health systems?
The Financial Times and Nikkei Inc will gather policy-makers, healthcare experts, business leaders and investors for an exclusive online discussion on how Asia’s health systems can best recover from the pandemic.
Industry-leading business leaders and speakers
Regional Industry Director - Manufacturing, Agribusiness & Services, South Asia & East Asia and Pacific
International Finance Corporation
Tetsuyu Institute Medical Corporation
Asia Companies and Markets News Editor
Asia Technology Correspondent
Senior Staff Writer
Better Health Systems
The pandemic has added pressure on Asia’s health systems, several of which are already burdened by a lack of financing, a rising rate of non-communicable diseases and inadequate infrastructure. What improvements should Asia’s policy-makers pursue? Is greater collaboration with the private sector the best solution to strengthen health systems in Asia?
How can digitalisation help to improve healthcare in the region? Are health-tech companies complementing healthcare provision in Asia?
The Business of Healthcare
In a post-pandemic health scenario in Asia, private healthcare providers and pharmaceuticals companies will need to balance profits, policies and people’s needs. What will be their biggest opportunities and newest challenges?
The critical necessity for greater investment and dynamic policy-making to improve Asia’s health systems
With policy-makers, healthcare providers, pharmaceutical companies, and technology and finance leaders to exchange ideas on Asia’s health
Why investing in Asia’s health offers abundant opportunities for profit, but challenges as well